Molecular pathogenesis of pancreatic ductal adenocarcinoma and clinical implications
- 1 July 2001
- journal article
- review article
- Published by Elsevier in Surgical Oncology
- Vol. 10 (1-2) , 1-23
- https://doi.org/10.1016/s0960-7404(01)00016-0
Abstract
No abstract availableKeywords
This publication has 97 references indexed in Scilit:
- Enhanced Expression of Silencer of Death Domains (SODD/BAG-4) in Pancreatic CancerBiochemical and Biophysical Research Communications, 2000
- Distinct types of diffuse large B-cell lymphoma identified by gene expression profilingNature, 2000
- The TGF-β signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancerOncogene, 1999
- Smad6 Suppresses TGF-β-Induced Growth Inhibition in COLO-357 Pancreatic Cancer Cells and Is Overexpressed in Pancreatic CancerBiochemical and Biophysical Research Communications, 1999
- A survey of telomerase activity in human cancerPublished by Elsevier ,1997
- Suppression of Pancreatic Cancer by the Dominant NegativerasMutant, N116YJournal of Surgical Research, 1996
- A gene for hereditary pancreatitis maps to chromosome 7q35Gastroenterology, 1996
- Molecular and immunochemical analyses ofRB1 and cyclin D1 in human ductal pancreatic carcinomas and cell linesMolecular Carcinogenesis, 1996
- Identification of the breast cancer susceptibility gene BRCA2Nature, 1995
- Mutation and Cancer: Statistical Study of RetinoblastomaProceedings of the National Academy of Sciences, 1971